Determination Under the Textile and Apparel Commercial Availability Provision of the Dominican Republic-Central America-United States Free Trade Agreement (“CAFTA-DR Agreement”), 21810-21811 [2017-09430]

Download as PDF 21810 Federal Register / Vol. 82, No. 89 / Wednesday, May 10, 2017 / Notices Council utilizes the Monitoring Committee recommendations at each June Council meeting when setting the subsequent years’ MSB specifications. Although other non-emergency issues not on the agenda may come before this group for discussion, in accordance with the Magnuson-Stevens Fishery Conservation and Management Act, those issues may not be the subject of formal action during this meeting. Actions of the Council will be restricted to those issues specifically identified in the agenda and any issues arising after publication of this notice that require emergency action under Section 305(c) of the Magnuson-Stevens Fishery Conservation and Management Act, provided the public has been notified of the Council’s intent to take action to address the emergency. Special Accommodations This meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aid should be directed to M. Jan Saunders, (302) 526–5251, at least 5 days prior to the meeting date. Dated: May 4, 2017. Tracey L. Thompson, Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2017–09436 Filed 5–9–17; 8:45 am] BILLING CODE 3510–22–P COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS Determination Under the Textile and Apparel Commercial Availability Provision of the Dominican RepublicCentral America-United States Free Trade Agreement (‘‘CAFTA–DR Agreement’’) The Committee for the Implementation of Textile Agreements. ACTION: Determination to add a product in unrestricted quantities to Annex 3.25 of the CAFTA–DR Agreement. AGENCY: The Committee for the Implementation of Textile Agreements (‘‘CITA’’) has determined that certain two-way stretch polyester/rayon/ spandex twill weave fabric, as specified below, is not available in commercial quantities in a timely manner in the CAFTA–DR countries. The product will be added to the list in Annex 3.25 of the CAFTA–DR Agreement in unrestricted quantities. jstallworth on DSK7TPTVN1PROD with NOTICES SUMMARY: DATES: Effective: May 10, 2017. FOR FURTHER INFORMATION CONTACT: Maria Goodman, Office of Textiles and VerDate Sep<11>2014 15:21 May 09, 2017 Jkt 241001 Apparel, U.S. Department of Commerce, (202) 482–3651. For Further Information On-Line: https://web.ita.doc.gov/tacgi/ CaftaReqTrack.nsf under ‘‘Approved Requests,’’ Reference number: 209.2017.04.03.Fabric.ST&RforMedline. SUPPLEMENTARY INFORMATION: Authority: The CAFTA–DR Agreement; Section 203(o)(4) of the Dominican RepublicCentral America-United States Free Trade Agreement Implementation Act (‘‘CAFTA– DR Implementation Act’’), Pub. Law 109–53; the Statement of Administrative Action, accompanying the CAFTA–DR Implementation Act; and Presidential Proclamation 7987 (February 28, 2006). Background The CAFTA–DR Agreement provides a list in Annex 3.25 for fabrics, yarns, and fibers that the Parties to the CAFTA–DR Agreement have determined are not available in commercial quantities in a timely manner in the territory of any Party. The CAFTA–DR Agreement provides that this list may be modified pursuant to Article 3.25.4 and 3.25.5, when the President of the United States determines that a fabric, yarn, or fiber is not available in commercial quantities in a timely manner in the territory of any Party. See Annex 3.25 of the CAFTA–DR Agreement; see also section 203(o)(4)(C) of the CAFTA–DR Implementation Act. The CAFTA–DR Implementation Act requires the President to establish procedures governing the submission of a request and providing opportunity for interested entities to submit comments and supporting evidence before a commercial availability determination is made. In Presidential Proclamations 7987 and 7996, the President delegated to CITA the authority under section 203(o)(4) of CAFTA–DR Implementation Act for modifying the Annex 3.25 list. Pursuant to this authority, on September 15, 2008, CITA published modified procedures it would follow in considering requests to modify the Annex 3.25 list of products determined to be not commercially available in the territory of any Party to CAFTA–DR (Modifications to Procedures for Considering Requests Under the Commercial Availability Provision of the Dominican Republic-Central America-United States Free Trade Agreement, 73 FR 53200) (‘‘CITA’s procedures’’). On April 3, 2017, the Chairman of CITA received a request for a Commercial Availability determination (‘‘Request’’) from Sandler, Travis and Rosenberg, P.A., on behalf of Medline Industries, Inc. for certain two-way PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 stretch polyester/rayon/spandex twill weave fabric. On April 4, 2017, in accordance with CITA’s procedures, CITA notified interested parties of the Request, which was posted on the dedicated Web site for CAFTA–DR Commercial Availability proceedings. In its notification, CITA advised that any Response with an Offer to Supply (‘‘Response’’) must be submitted by April 17, 2017, and any Rebuttal Comments to a Response must be submitted by April 21, 2017, in accordance with sections 6 and 7 of CITA’s procedures. No interested entity submitted a Response to the Request advising CITA of its objection to the Request and its offer to supply the subject product. In accordance with section 203(o)(4)(C) of the CAFTA–DR Implementation Act, and section 8(c)(2) of CITA’s procedures, as no interested entity submitted a Response objecting to the Request and providing an offer to supply the subject product, CITA has determined to add the specified fabric to the list in Annex 3.25 of the CAFTA– DR Agreement. The subject product has been added to the list in Annex 3.25 of the CAFTA– DR Agreement in unrestricted quantities. A revised list has been posted on the dedicated Web site for CAFTA–DR Commercial Availability proceedings, at https://otexa.trade.gov/ caftaannex325.htm. Specifications: Two-way Stretch Polyester/Rayon/Spandex Twill Weave Fabric HTS: 5515.11.00 Fiber Content: 69–75% polyester; 20– 26% rayon, 2–8% spandex Warp: Plied polyester/rayon staple with spandex filament Filling: Plied textured polyester filament with spandex filament Thread count: 47.2–51.2 warp ends per linear cm (120–130 warp ends per linear inch); 35.43–39.37 filling ends per linear cm (90–100 filling ends per linear inch) Fabric weight: 194 to 206 grams per meter squared (5.7 to 6.1 ounces per square yard) Finishing process: Softened Coloration: Piece dyed, yarn dyed, bleached and printed Performance Criteria Dimensional Stability/Shrinkage (AATCC 135): +/¥3% Colorfastness to Laundering (AATCC 61): >/= 4.0 color change; >/= 3.5 staining for light colors (3.0 for dark colors) Colorfastness to Crocking (AATCC 8): >/= 4.0 dry; >/= 3 wet for light colors (2.5 for dark colors). E:\FR\FM\10MYN1.SGM 10MYN1 Federal Register / Vol. 82, No. 89 / Wednesday, May 10, 2017 / Notices Note: The yarn size designations describe a range of yarn specifications for yarn before knitting, dyeing and finishing of the fabric. They are intended as specifications to be followed by the mill in sourcing yarn used to produce the fabric. Dyeing, finishing and knitting can alter the characteristic of the yarn as it appears in the finished fabric. This specification therefore includes yarn sizes provided that the variation occurs after processing of the greige yarn and production of the fabric. The specifications for the fabric apply to the fabric itself prior to cutting and sewing of the finished garment. Such processing may alter the measurements. Terry Labat, Acting Chairman, Committee for the Implementation of Textile Agreements. [FR Doc. 2017–09430 Filed 5–9–17; 8:45 am] BILLING CODE 3510–DR–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Assistant Secretary of Defense (Health Affairs), Department of Defense. ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The Department of Defense (DoD) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. DATES: Open to the public Thursday, June 22, 2017 from 9:00 a.m. to 12:00 p.m. SUMMARY: The address of the open meeting is Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Edward Norton, 703–681–2890 (Voice), 703–681–1940 (Facsimile), dha.ncr.health-it.mbx.baprequests@ mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Web site: https://www.health.mil/About-MHS/ Other-MHS-Organizations/BeneficiaryAdvisory-Panel. The most up-to-date changes to the meeting agenda can be found on the Web site. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. jstallworth on DSK7TPTVN1PROD with NOTICES ADDRESSES: VerDate Sep<11>2014 15:21 May 09, 2017 Jkt 241001 Purpose of the Meeting: The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). Agenda: 1. Sign-In. 2. Welcome and Opening Remarks. 3. Public Citizen Comments. 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item). a. Ophthalmic-1 Agents. b. Pulmonary Miscellaneous. 5. Newly Approved Drugs Review. 6. Pertinent Utilization Management Issues. 7. Panel Discussions and Vote. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 Code of Federal Regulations (CFR) 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Written Statements: Pursuant to 41 CFR 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be obtained from the General Services Administration’s Federal Advisory Committee Act Database at https://facadatabase.gov/. Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting, then these statements must be submitted no later than 5 business days prior to the meeting in question. The DFO will review all submitted written statements and provide copies to all the committee members. Public Comments: In addition to written statements, the Panel will set aside 1 hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice; but if they still want to address the Panel, then they will be afforded the opportunity to register to address the Panel. The Panel’s DFO will have a ‘‘Sign-Up Roster’’ available at the Panel meeting for registration on a first-come, first-serve basis. Those wishing to PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 21811 address the Panel will be given no more than 5 minutes to present their comments, and at the end of the 1-hour time period, no further public comments will be accepted. Anyone who signs-up to address the Panel, but is unable to do so due to the time limitation, may submit their comments in writing; however, they must understand that their written comments may not be reviewed prior to the Panel’s deliberation. To ensure timeliness of comments for the official record, the Panel encourages that individuals and interested groups consider submitting written statements instead of addressing the Panel. Dated: May 5, 2017. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2017–09450 Filed 5–9–17; 8:45 am] BILLING CODE 5001–06–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OAR–2011–0742; FRL–9959–69– OEI] Information Collection Request Submitted to OMB for Review and Approval; Comment Request; Air Pollution Regulations for Outer Continental Shelf (OCS) Activities Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), ‘‘Air Pollution Regulations for Outer Continental Shelf (OCS) Activities’’ to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR. Public comments were previously requested via the Federal Register on May 29, 2015, during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. DATES: Additional comments may be submitted on or before June 9, 2017. ADDRESSES: Submit your comments, referencing Docket ID No. EPA–HQ– OAR–2011–0724, to (1) the EPA online using https://www.regulations.gov (our SUMMARY: E:\FR\FM\10MYN1.SGM 10MYN1

Agencies

Committee for the Implementation of Textile Agreements

[Federal Register Volume 82, Number 89 (Wednesday, May 10, 2017)]
[Notices]
[Pages 21810-21811]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09430]


=======================================================================
-----------------------------------------------------------------------

COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS


Determination Under the Textile and Apparel Commercial 
Availability Provision of the Dominican Republic-Central America-United 
States Free Trade Agreement (``CAFTA-DR Agreement'')

AGENCY: The Committee for the Implementation of Textile Agreements.

ACTION: Determination to add a product in unrestricted quantities to 
Annex 3.25 of the CAFTA-DR Agreement.

-----------------------------------------------------------------------

SUMMARY: The Committee for the Implementation of Textile Agreements 
(``CITA'') has determined that certain two-way stretch polyester/rayon/
spandex twill weave fabric, as specified below, is not available in 
commercial quantities in a timely manner in the CAFTA-DR countries. The 
product will be added to the list in Annex 3.25 of the CAFTA-DR 
Agreement in unrestricted quantities.

DATES: Effective: May 10, 2017.

FOR FURTHER INFORMATION CONTACT: Maria Goodman, Office of Textiles and 
Apparel, U.S. Department of Commerce, (202) 482-3651.
    For Further Information On-Line: https://web.ita.doc.gov/tacgi/CaftaReqTrack.nsf under ``Approved Requests,'' Reference number: 
209.2017.04.03.Fabric.ST&RforMedline.

SUPPLEMENTARY INFORMATION: 

    Authority: The CAFTA-DR Agreement; Section 203(o)(4) of the 
Dominican Republic-Central America-United States Free Trade 
Agreement Implementation Act (``CAFTA-DR Implementation Act''), Pub. 
Law 109-53; the Statement of Administrative Action, accompanying the 
CAFTA-DR Implementation Act; and Presidential Proclamation 7987 
(February 28, 2006).

Background

    The CAFTA-DR Agreement provides a list in Annex 3.25 for fabrics, 
yarns, and fibers that the Parties to the CAFTA-DR Agreement have 
determined are not available in commercial quantities in a timely 
manner in the territory of any Party. The CAFTA-DR Agreement provides 
that this list may be modified pursuant to Article 3.25.4 and 3.25.5, 
when the President of the United States determines that a fabric, yarn, 
or fiber is not available in commercial quantities in a timely manner 
in the territory of any Party. See Annex 3.25 of the CAFTA-DR 
Agreement; see also section 203(o)(4)(C) of the CAFTA-DR Implementation 
Act.
    The CAFTA-DR Implementation Act requires the President to establish 
procedures governing the submission of a request and providing 
opportunity for interested entities to submit comments and supporting 
evidence before a commercial availability determination is made. In 
Presidential Proclamations 7987 and 7996, the President delegated to 
CITA the authority under section 203(o)(4) of CAFTA-DR Implementation 
Act for modifying the Annex 3.25 list. Pursuant to this authority, on 
September 15, 2008, CITA published modified procedures it would follow 
in considering requests to modify the Annex 3.25 list of products 
determined to be not commercially available in the territory of any 
Party to CAFTA-DR (Modifications to Procedures for Considering Requests 
Under the Commercial Availability Provision of the Dominican Republic-
Central America-United States Free Trade Agreement, 73 FR 53200) 
(``CITA's procedures'').
    On April 3, 2017, the Chairman of CITA received a request for a 
Commercial Availability determination (``Request'') from Sandler, 
Travis and Rosenberg, P.A., on behalf of Medline Industries, Inc. for 
certain two-way stretch polyester/rayon/spandex twill weave fabric. On 
April 4, 2017, in accordance with CITA's procedures, CITA notified 
interested parties of the Request, which was posted on the dedicated 
Web site for CAFTA-DR Commercial Availability proceedings. In its 
notification, CITA advised that any Response with an Offer to Supply 
(``Response'') must be submitted by April 17, 2017, and any Rebuttal 
Comments to a Response must be submitted by April 21, 2017, in 
accordance with sections 6 and 7 of CITA's procedures. No interested 
entity submitted a Response to the Request advising CITA of its 
objection to the Request and its offer to supply the subject product.
    In accordance with section 203(o)(4)(C) of the CAFTA-DR 
Implementation Act, and section 8(c)(2) of CITA's procedures, as no 
interested entity submitted a Response objecting to the Request and 
providing an offer to supply the subject product, CITA has determined 
to add the specified fabric to the list in Annex 3.25 of the CAFTA-DR 
Agreement.
    The subject product has been added to the list in Annex 3.25 of the 
CAFTA-DR Agreement in unrestricted quantities. A revised list has been 
posted on the dedicated Web site for CAFTA-DR Commercial Availability 
proceedings, at https://otexa.trade.gov/caftaannex325.htm.

Specifications: Two-way Stretch Polyester/Rayon/Spandex Twill Weave 
Fabric
HTS: 5515.11.00
Fiber Content: 69-75% polyester; 20-26% rayon, 2-8% spandex
Warp: Plied polyester/rayon staple with spandex filament
Filling: Plied textured polyester filament with spandex filament
Thread count: 47.2-51.2 warp ends per linear cm (120-130 warp ends per 
linear inch); 35.43-39.37 filling ends per linear cm (90-100 filling 
ends per linear inch)
Fabric weight: 194 to 206 grams per meter squared (5.7 to 6.1 ounces 
per square yard)
Finishing process: Softened
Coloration: Piece dyed, yarn dyed, bleached and printed

Performance Criteria

Dimensional Stability/Shrinkage (AATCC 135): +/-3%
Colorfastness to Laundering (AATCC 61): >/= 4.0 color change; >/= 3.5 
staining for light colors (3.0 for dark colors)
Colorfastness to Crocking (AATCC 8): >/= 4.0 dry; >/= 3 wet for light 
colors (2.5 for dark colors).


[[Page 21811]]


    Note: The yarn size designations describe a range of yarn 
specifications for yarn before knitting, dyeing and finishing of the 
fabric. They are intended as specifications to be followed by the 
mill in sourcing yarn used to produce the fabric. Dyeing, finishing 
and knitting can alter the characteristic of the yarn as it appears 
in the finished fabric. This specification therefore includes yarn 
sizes provided that the variation occurs after processing of the 
greige yarn and production of the fabric. The specifications for the 
fabric apply to the fabric itself prior to cutting and sewing of the 
finished garment. Such processing may alter the measurements.


Terry Labat,
Acting Chairman, Committee for the Implementation of Textile 
Agreements.
[FR Doc. 2017-09430 Filed 5-9-17; 8:45 am]
BILLING CODE 3510-DR-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.